Little Green Pharma Valuation Multiples

Discover revenue and EBITDA valuation multiples for Little Green Pharma and similar public comparables like Planet 13, WM Tech, MariMed, iAnthus Capital Holdings and more.

Little Green Pharma Overview

About Little Green Pharma

Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets.


Founded

2016

HQ

Australia

Employees

N/A

Financials (LTM)

Revenue: $43M
EBITDA: $5M

EV

$46M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Little Green Pharma Financials

Little Green Pharma reported last 12-month revenue of $43M and EBITDA of $5M.

In the same LTM period, Little Green Pharma generated $5M in EBITDA and $201K in net income.

Revenue (LTM)


Little Green Pharma P&L

In the most recent fiscal year, Little Green Pharma reported revenue of $30M and EBITDA of $4M.

Little Green Pharma is unprofitable as of last fiscal year, with gross margin of 69%, EBITDA margin of 12%, and net margin of (3%).

See analyst estimates for Little Green Pharma
LTMLast FY202320242025202620272028
Revenue$43M$30M$17M$24M$29M
Gross Profit-$21M$9M$16M$20M
Gross Margin-69%53%65%71%
EBITDA$5M$4M($3M)($1M)$1M
EBITDA Margin12%12%(19%)(5%)5%
EBIT Margin5%5%(52%)(17%)2%
Net Profit$201K($984K)($6M)$318K($157K)
Net Margin0%(3%)(35%)1%(1%)
Net Debt-$1M---

Financial data powered by Morningstar, Inc.

Little Green Pharma Stock Performance

Little Green Pharma has current market cap of $44M, and enterprise value of $46M.

Market Cap Evolution


Little Green Pharma's stock price is $0.05.

Little Green Pharma share price increased by 26.5% in the last 30 days.

See more trading valuation data for Little Green Pharma
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$46M$44M-0.2%26.5%--$-0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Little Green Pharma Valuation Multiples

Little Green Pharma trades at 1.1x EV/Revenue multiple, and 8.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Little Green Pharma

EV / Revenue (LTM)


Little Green Pharma Financial Valuation Multiples

As of July 19, 2026, Little Green Pharma has market cap of $44M and EV of $46M.

Little Green Pharma has a P/E ratio of 217.8x.

LTMLast FY202320242025202620272028
EV/Revenue1.1x1.5x2.7x1.9x1.6x
EV/EBITDA8.6x12.1x(14.7x)(39.4x)35.5x
EV/EBIT22.2x31.0x(5.2x)(11.5x)93.5x
EV/Gross Profit-2.2x5.1x3.0x2.3x
P/E217.8x(44.5x)(7.4x)137.7xn/m
EV/FCF73.9x(71.5x)(16.5x)(41.8x)(58.3x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Little Green Pharma Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Little Green Pharma Margins & Growth Rates

Little Green Pharma grew revenue by 139% and EBITDA by 137% in the last fiscal year.

In the most recent fiscal year, Little Green Pharma reported gross margin of 69%, EBITDA margin of 12%, and net margin of (3%).

See estimated margins and future growth rates for Little Green Pharma

Little Green Pharma Margins

Last FY202420252026202720282029
Gross Margin69%65%71%69%
EBITDA Margin12%(5%)5%12%
EBIT Margin5%(17%)2%6%
Net Margin(3%)1%(1%)3%
FCF Margin(2%)(5%)(3%)4%

Little Green Pharma Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth139%41%21%116%
Gross Profit Growth138%73%30%112%
EBITDA Growth137%(63%)(211%)458%
EBIT Growth197%(54%)(112%)645%
Net Profit Growth(405%)(105%)(149%)(1376%)
FCF Growth(653%)(61%)(28%)(417%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Little Green Pharma Operational KPIs

Little Green Pharma's Rule of 40 is 128% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Little Green Pharma's Rule of X is 302% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Little Green Pharma
LTMLast FY202320242025202620272028
Rule of 4088%128%---
Bessemer Rule of X200%302%---
S&M Expenses to Revenue-15%32%23%17%
G&A Expenses to Revenue-34%17%36%36%
R&D Expenses to Revenue0%0%26%5%0%
Opex to Revenue-64%105%82%69%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Little Green Pharma Competitors

Little Green Pharma competitors include Planet 13, WM Tech, MariMed, iAnthus Capital Holdings, Peak Processing, Vitura Health, Humanoid Global Holdings, SynBiotic, HYTN Innovations and Ascend Wellness Holdings.

Most Little Green Pharma public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Planet 130.9x1.0x(9.4x)(16.5x)
WM Tech0.1x0.1x0.3x0.4x
MariMed0.7x0.7x6.5x6.7x
iAnthus Capital Holdings1.7x-13.9x-
Peak Processing1.9x-(9.4x)-
Vitura Health0.2x-3.8x-
Humanoid Global Holdings1138.4x-(7.2x)-
SynBiotic0.8x-(5.7x)-

This data is available for Pro users. Sign up to see all Little Green Pharma competitors and their valuation data.

Start Free Trial

Little Green Pharma VC Funding History

Before going public, Little Green Pharma raised $8M in total equity funding, across 2 rounds.


Little Green Pharma Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Jul-19Series A-$6M-Little Green Pharma raised A$9 million in a pre-IPO convertible note fundraising in July 2019, with the notes subsequently converting into shares upon the company's ASX listing in February 2020. The company operated a GMP-compliant indoor cultivation facility in South-West Western Australia producing medicinal cannabis oil, flower, and vaporiser products for the Australian market. For the financial year ended 30 June 2020 (the closest audited reporting period to the July 2019 fundraising), Little Green Pharma generated revenue of more than A$2.2 million from the sale of over 14,860 bottles of medicinal cannabis product, compared to A$1,676 bottles in the prior year. The company achieved a gross margin of 52% in FY2020, up from 41% in the previous year, supported by increasing scale and operating efficiencies, and had more than 4,560 patients prescribed its products by the end of the year with over 315 healthcare professionals recommending its offerings.
Oct-17Seed-$2M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Little Green Pharma

When was Little Green Pharma founded?Little Green Pharma was founded in 2016.
Where is Little Green Pharma headquartered?Little Green Pharma is headquartered in Australia.
Is Little Green Pharma publicly listed?Yes, Little Green Pharma is a public company listed on Australian Securities Exchange.
What is the stock symbol of Little Green Pharma?Little Green Pharma trades under LGP ticker.
When did Little Green Pharma go public?Little Green Pharma went public in 2020.
Who are competitors of Little Green Pharma?Little Green Pharma main competitors include Planet 13, WM Tech, MariMed, iAnthus Capital Holdings, Peak Processing, Vitura Health, Humanoid Global Holdings, SynBiotic, HYTN Innovations, Ascend Wellness Holdings.
What is the current market cap of Little Green Pharma?Little Green Pharma's current market cap is $44M.
What is the current revenue of Little Green Pharma?Little Green Pharma's last 12 months revenue is $43M.
What is the current revenue growth of Little Green Pharma?Little Green Pharma revenue growth (NTM/LTM) is 75%.
What is the current EV/Revenue multiple of Little Green Pharma?Current revenue multiple of Little Green Pharma is 1.1x.
What is the current EBITDA of Little Green Pharma?Little Green Pharma's last 12 months EBITDA is $5M.
What is Little Green Pharma's EBITDA margin?Little Green Pharma's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of Little Green Pharma?Current EBITDA multiple of Little Green Pharma is 8.6x.
What is the current FCF of Little Green Pharma?Little Green Pharma's last 12 months FCF is $623K.
What is Little Green Pharma's FCF margin?Little Green Pharma's last 12 months FCF margin is 1%.
What is the current EV/FCF multiple of Little Green Pharma?Current FCF multiple of Little Green Pharma is 73.9x.
How many companies Little Green Pharma has acquired to date?Little Green Pharma hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Little Green Pharma has invested to date?Little Green Pharma hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Little Green Pharma

Lists including Little Green Pharma

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial